Dyadic International (DYAI) Stock: Buy, Sell, or Hold?
DYAI - Dyadic International, Inc.
$0.43
-0.02 (-3.37%)
▼
5d:
-1.29%
30d:
-19.26%
90d:
-54.32%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When DYAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DYAI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DYAI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: DYAI is currently trading at $0.43, which is considered slightly low relative to its 30-day fair value range of $0.41 to $0.58. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.4) compared to its historical average (39.7). Remarkably, the market is currently pricing in an annual earnings decline of 22.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DYAI is in a downtrend. Immediate support is located at $0.38, while resistance sits at $0.50. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: DYAI scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+1180.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DYAI is in a downtrend. Immediate support is located at $0.38, while resistance sits at $0.50. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: DYAI scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+1180.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.41 -
$0.58
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (72/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 1180.3% below Wall St target ($5.50)
- CAUTION: Bottoming setup, but lagging the sector by 30% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.41 -
$0.58
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.38
Resistance Level
$0.50
Current Trend
Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.44
Wall Street Target
$5.50
(+1180.3%)
Revenue Growth (YoY)
-0.6%
Profit Margin
-200.5%
Valuation Discount vs History
-22.6% cheaper
PE vs Historical
18.4 vs 39.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-22.6%
(market-implied from PE analysis)
1-Year Target
$0.39
(-10%)
2-Year Target
$0.35
(-19%)
3-Year Target
$0.31
(-27%)
3-Yr Target (if PE normalizes)
(PE: 18→40)
$0.67
(+57%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.4 to 39.7
Stabilization Target:
$0.93
(+115.3%)
PE Expansion Potential:
+115.3%
Share & Embed Analysis
Last updated: October 02, 2026 3:56 AM ET
Data refreshes hourly during market hours. Next update: 4:56 AM
Data refreshes hourly during market hours. Next update: 4:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DYAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 63 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 55 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 58 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
10 analysts |
$70 | 70 BUY |
